An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome
Izuho Hatada(National Cerebral and Cardiovascular Center), Tsunehiro Mukai(National Cerebral and Cardiovascular Center), Hirofumi Ohashi(Aichi Medical University), Akira Nabetani(National Cerebral and Cardiovascular Center), Akira Okada(Nihon University), Hiroko Morisaki(National Cerebral and Cardiovascular Center), Yoshimitsu Fukushima(Saitama Children's Medical Center), Masahiro Inoue(Kyoto University), Yasuhiko Kaneko(MRC Laboratory of Molecular Biology), Yosuke Komoto(The University of Osaka), Masahiro Nakayama(Osaka International Cancer Institute), Norio Niikawa(Nagasaki University), Sachiko Oh‐ishi(National Cerebral and Cardiovascular Center)
Cited by 385
Related Papers
Kabuki make‐up (Niikawa‐Kuroki) syndrome: A study of 62 patients
|American Journal of Medical Genetics|1988|457
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.
|Proceedings of the National Academy of Sciences|1991|371
Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse
|Nature Genetics|1995|291
Analysis of germline CDKN1C (p57<sup>KIP2</sup>) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation
|Journal of Medical Genetics|1999|178
Common variants in CASP3 confer susceptibility to Kawasaki disease
|Human Molecular Genetics|2010|176